Clinical Trial

Co-Developing an HIV Prevention Program for Women in Ghana

Study acronym: WISEWOMAN
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The WISE Woman Study is a research project in Ghana focused on improving HIV prevention among young women aged 18 to 35. In Ghana, young women are at higher risk of HIV but often lack access to the right information and services. This study will first work with young women and community partners to co-develop a youth-friendly and women-centered HIV prevention program. The program will focus on two proven strategies: HIV self-testing (HIVST) and pre-exposure prophylaxis (PrEP), a medicine that helps prevent HIV. After the program is created, researchers will test it with 50 young women in Greater Accra and the Eastern Region to see if it's acceptable, easy to use, and if it helps increase knowledge and use of HIVST and PrEP. The intervention will be delivered through WhatsApp and community-based workshops to ensure privacy and reach. Participants will complete surveys and take part in discussions and interviews to share their feedback. This research will help build better HIV prevention strategies tailored to the needs of young women in Ghana.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-05-30; most recent amendment 2026-01-23.
Status change: Not Yet Recruiting → Active, Not Recruiting 2025-09-09
Trial Details
NCT Number NCT07003789
Lead Sponsor State University of New York at Buffalo
Conditions HIV Prevention, Women's Health, Sexual and Reproductive Health
Enrollment 65 participants
Start Date 2025-07-01
Primary Completion 2026-12-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-01-26